comparemela.com

Latest Breaking News On - Theis terwey - Page 1 : comparemela.com

GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression

18.01.2024 - DUBLIN, Ireland, Jan. 18, 2024 (GLOBE NEWSWIRE) - GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today announced that it recently . Seite 1

Theis terweyGh researchGh research chartH research kursH research aktie

GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression

DUBLIN, Ireland, Jan. 18, 2024 GH Research PLC , a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today announced.

Julie ryanTheis terweyEuropean patent officeGh researchExchange commissionGlobenewswire incPatent office

GH Research Announces Grant of European Patent Covering all

DUBLIN, Ireland, Jan. 18, 2024 (GLOBE NEWSWIRE) GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming.

Theis terweyJulie ryanEuropean patent officeGlobe newswire gh researchExchange commissionGh researchNasdaq ghrsGh research plcMental health

vimarsana © 2020. All Rights Reserved.